Sign Up to like & get
recommendations!
1
Published in 2022 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.03238-22
Abstract: The global rise in antibiotic-resistant nontuberculous mycobacteria has prompted the urgent need for new antimicrobials, especially oral antibiotics. Currently, adverse effects have limited the use of tetracycline-class antibiotics, particularly tigecycline (TGC), in the treatment of…
read more here.
Keywords:
rapidly growing;
growing mycobacteria;
eravacycline omadacycline;
abscessus subsp ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2022.1043736
Abstract: In this study, we investigated the in vitro activity and resistance mechanisms of the new generation tetracycline agents, namely eravacycline, omadacycline, and tigecycline, against Staphylococcus aureus isolates. A total of 1,017 non-duplicate S. aureus isolates…
read more here.
Keywords:
omadacycline tigecycline;
eravacycline omadacycline;
tigecycline;
aureus isolates ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11101298
Abstract: For decades, the spread of multidrug-resistant (MDR) Acinetobacter baumannii has been rampant in critically ill, hospitalized patients. Traditional antibiotic therapies against this pathogen have been failing, leading to rising concerns over management options for patients.…
read more here.
Keywords:
omadacycline;
eravacycline omadacycline;
extensively drug;
acinetobacter baumannii ... See more keywords